Alimera Sciences to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference
Alimera Sciences (Nasdaq: ALIM) announced that CEO Rick Eiswirth will present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference from February 8-11, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alimera Sciences (Nasdaq: ALIM) announced that CEO Rick Eiswirth will present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference from February 8-11, 2022. His presentation is scheduled for February 9 at 10:00 AM ET. Additionally, Eiswirth and CFO Phil Jones will hold one-on-one meetings with investors on February 10-11. Alimera focuses on retinal health and aims to enhance patients' vision longevity. For more details, visit www.alimerasciences.com.
Details
News Market Reaction – ALIM
The recorded move for ALIM in the trading session of this news was -6.52%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ATLANTA, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer will present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference, which is being held virtually from February 8 – 11, 2022.
Mr. Eiswirth will deliver his corporate presentation on Wednesday, February 9 at 10:00 AM ET.
Event Webcast URL: https://www.webcaster4.com/Webcast/Page/2840/44550
Mr. Eiswirth and Phil Jones, Alimera’s Chief Financial Officer, will be available for one-on-one investor meetings on February 10 – 11, 2022.
To receive additional information or to schedule a one-on-one meeting, please email angie.wright@issuerdirect.com.
About Alimera Sciences, Inc.
Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
| For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com | For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.